The OraStretch Press jaw rehabilitation system has been approved onto the NHS Drug Tariff – effective from August 2026! This means clinicians can now prescribe the device directly, granting greater access for patients recovering jaw mobility.
OraStretch delivers controlled, gradual stretching of the jaw to help restore range of motion following surgery, trauma, radiotherapy, trismus, and more. It offers patients the ability to take active control over their recovery, from the comfort of their own home.
This Drug Tariff inclusion removes the longstanding funding barrier, giving NHS practitioners – including dentists, speech and language therapists, and nurse consultants – a simple route to ensure their patients have the very best rehabilitation tool.
To find out more about prescribing OraStretch on the NHS Drug Tariff, contact the Total TMJ team today!
For more information visit totaltmj.co.uk, call 01202 313702 or email info@totaltmj.co.uk
